Goyal M, Fladt J, Coutinho JM, McDonough R, Ospel J. Endovascular treatment for cerebral venous thrombosis: current status, challenges, and opportunities. J NeuroIntervent Surg. 2022;14(8):788–93. https://doi.org/10.1136/neurintsurg-2021-018101.

Article  Google Scholar 

Ilyas A, Chen CJ, Raper DM, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J NeuroIntervent Surg. 2017;9(11):1086–92. https://doi.org/10.1136/neurintsurg-2016-012938.

Article  Google Scholar 

Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352(17):1791–8. https://doi.org/10.1056/NEJMra042354.

Article  CAS  PubMed  Google Scholar 

• Bose G, Graveline J, Yogendrakumar V, et al. Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review. BMJ Open. 2021;11(2):e040212. https://doi.org/10.1136/bmjopen-2020-040212. This systematic review provides a comparative analysis between the different types of DOACs.

Pan Y, Elm JJ, Li H, et al. Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of clopidogrel in high-risk patients with acute non-disabling cerebrovascular events (CHANCE) and platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trials. JAMA Neurol. 2019;76(12):1466. https://doi.org/10.1001/jamaneurol.2019.2531.

Article  PubMed  PubMed Central  Google Scholar 

Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35(3):664–70. https://doi.org/10.1161/01.STR.0000117571.76197.26.

Article  PubMed  Google Scholar 

van Dam LF, van Walderveen MAA, Kroft LJM, et al. Current imaging modalities for diagnosing cerebral vein thrombosis – a critical review. Thromb Res. 2020;189:132–9. https://doi.org/10.1016/j.thromres.2020.03.011.

Article  CAS  PubMed  Google Scholar 

Saposnik G, Barinagarrementeria F, R Brown Jr RD, CD. Bushnell, BCucchiara, MCushman, G deVeber, Jose M. Ferro and Fong Y. Tsal and on behalf of the American Heart Association Stroke Council and the Council on Epidemiology and Prevention Stroke 2011;42:1158–1192. https://doi.org/10.1161/STR.0b013e31820a8364.

Einhäupl K, Villringer A, Mehraein S, et al. Heparin treatment in sinus venous thrombosis. The Lancet. 1991;338(8767):597–600. https://doi.org/10.1016/0140-6736(91)90607-Q.

Article  Google Scholar 

de Bruijn SFTM, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30(3):484–8. https://doi.org/10.1161/01.STR.30.3.484.

Article  PubMed  Google Scholar 

Coutinho J, de Bruijn SF, deVeber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev. 2011;2011(8):CD002005. https://doi.org/10.1002/14651858.CD002005.pub2.

Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195–221. https://doi.org/10.1177/2396987317719364.

Article  PubMed  PubMed Central  Google Scholar 

Misra U, Kalita J, Chandra S, Kumar B, Bansal V. Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol. 2012;19(7):1030–6.

Article  CAS  PubMed  Google Scholar 

Afshari D, Moradian N, Nasiri F, Razazian N, Bostani A, Sariaslani P. The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis. NSJ. 2015;20(4):357–61. https://doi.org/10.17712/nsj.2015.4.20150375.

Article  Google Scholar 

Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Bousser MG, Stam J. Unfractionated or low–molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke. 2010;41(11):2575–80. https://doi.org/10.1161/STROKEAHA.110.588822.

Article  CAS  PubMed  Google Scholar 

Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation. 2010;121(25):2740–6. https://doi.org/10.1161/CIRCULATIONAHA.109.927046.

Article  PubMed  Google Scholar 

Miranda B, Aaron S, Arauz A, et al. The benefit of EXtending oral antiCOAgulation treatment (EXCOA) after acute cerebral vein thrombosis (CVT): EXCOA-CVT cluster randomized trial protocol. Int J Stroke. 2018;13(7):771–4. https://doi.org/10.1177/1747493018778137.

Article  PubMed  Google Scholar 

Yaghi S, Shu L, Bakradze E, et al. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke. 2022;53(3):728–38. https://doi.org/10.1161/STROKEAHA.121.037541.ACTION-CVTcomparedDOACstowarfarin,findingsignificantlylowerhemorrhagerisksinDOAC-treatedpatients.

Article  CAS  PubMed  Google Scholar 

Ferro JM, Coutinho JM, Dentali F, et al. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol. 2019;76(12):1457. https://doi.org/10.1001/jamaneurol.2019.2764.

Article  PubMed  PubMed Central  Google Scholar 

Ferro JM, Bendszus M, Jansen O, et al. Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis. Int J Stroke. 2022;17(2):189–197. https://doi.org/10.1177/17474930211006303.

Wasay M, Khan M, Rajput HM, et al. New oral anticoagulants versus warfarin for cerebral venous thrombosis: a multi-center, observational study. J Stroke. 2019;21(2):220–3. https://doi.org/10.5853/jos.2019.00150.

Article  PubMed  PubMed Central  Google Scholar 

Connor P, Sánchez van Kammen M, Lensing AWA, et al. Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT). Blood Adv. 2020;4(24):6250–6258. https://doi.org/10.1182/bloodadvances.2020003244.

Li H, Yao M, Liao S, Chen J, Yu J. Comparison of novel oral anticoagulants and vitamin k antagonists in patients with cerebral venous sinus thrombosis on efficacy and safety: a systematic review. Front Neurol. 2020;11:597623. https://doi.org/10.3389/fneur.2020.597623.

Nepal G, Kharel S, Bhagat R, et al. Safety and efficacy of direct oral anticoagulants in cerebral venous thrombosis: a meta-analysis. Acta Neurol Scand. 2021;145:10–23. https://doi.org/10.1111/ane.13506.

Article  CAS  PubMed  Google Scholar 

Field TS, Dizonno V, Hill M. Study of rivaroxaban for CeREbral venous Thrombosis (SECRET). Int J Stroke. 2019;14(3 suppl). https://doi.org/10.1177/1747493019872147.

Coutinho, J. Direct oral anticoagulants for the treatment of cerebral venous thrombosis (DOAC-CVT). NCT04660747. Updated February 28, 2022.  https://clinicaltrials.gov/ct2/show/NCT04660747. Accessed 6 Feb 2023.

Ferro JM, Canhao P, Caso V, Agnelli G, Paciaroni M. Handbook on cerebral venous thrombosis: complications of cerebral vein and sinus thrombosis. Front Neurol Neurosci. 2008;23:161–71. https://doi.org/10.1159/000111377.

Article  PubMed  Google Scholar 

Putaala J, Hiltunen S, Salonen O, Kaste M, Tatlisumak T. Recanalization and its correlation to outcome after cerebral venous thrombosis. J Neurol Sci. 2010;292(1–2):11–5. https://doi.org/10.1016/j.jns.2010.02.017.

Article  PubMed  Google Scholar 

de Sousa AD, Neto LL, Canhão P, Ferro JM. Recanalization in cerebral venous thrombosis: a systematic review and meta-analysis. Stroke. 2018;49(8):1828–35. https://doi.org/10.1161/STROKEAHA.118.022129.

Article  Google Scholar 

Vanukuri KN, Pedapati R, Shanmugam S, Hazeena P, Rangasami R, Venkatasubramanian S. Effect of recanalization on clinical outcomes in patients with cerebral venous thrombosis – an ambispective study. Eur J Radiol. 2022;153:110385. https://doi.org/10.1016/j.ejrad.2022.110385.

de Sousa AD, Neto LL, Arauz A, et al. Early recanalization in patients with cerebral venous thrombosis treated with anticoagulation. Stroke. 2020;51(4):1174–81. https://doi.org/10.1161/STROKEAHA.119.028532.

Article  CAS  PubMed  Google Scholar 

Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–65. https://doi.org/10.1038/nrneurol.2017.104.

Article  PubMed  Google Scholar 

Coutinho JM, Zuurbier SM, Bousser MG, et al. Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial. JAMA Neurol. 2020;77(8):966. https://doi.org/10.1001/jamaneurol.2020.1022.TheTO-ACTtrialwasthefirstrandomizedstudyofendovasculartreatmentforCVT.

Article  PubMed  PubMed Central  Google Scholar 

•• Siegler JE, Shu L, Yaghi S, et al. Endovascular therapy for cerebral vein thrombosis: a propensity-matched analysis of anticoagulation in the treatment of cerebral venous thrombosis. Neurosurgery. 2022;91(5):749–755. https://doi.org/10.1227/neu.0000000000002098. This study analyzed endovascular treatment of patients from the ACTION-CVT trial and suggests improved outcomes in patients with complete recanalization.

Nyberg EM, Case D, Nagae LM, et al. The addition of endovascular intervention for dural venous sinus thrombosis: single-center experience and review of literature. J Stroke Cerebrovasc Dis. 2017;26(10):2240–7. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.05.006.

Article  PubMed  Google Scholar 

Guo X, Sun J, Lu X, Guan S. Intrasinus thrombolysis for cerebral venous sinus thrombosis: single-center experience. Front Neurol. 2019;10:1185. https://doi.org/10.3389/fneur.2019.01185.

Article  PubMed  PubMed Central  Google Scholar 

Bücke P, Hellstern V, Cimpoca A, et al. Endovascular treatment of intracranial vein and venous sinus thrombosis—a systematic review. JCM. 2022;11(14):4215. https://doi.org/10.3390/jcm11144215.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naik A, Smith E, Dharnipragada R, et al. Endovascular and medical management of cerebral venous thrombosis: a systematic review and network meta-analysis. World Neurosurg. 2022;165:e197–205. https://doi.org/10.1016/j.wneu.2022.05.142.

Article  PubMed  Google Scholar 

Paybast S, Mohamadian R, Emami A, et al. Safety and efficacy of endovascular thrombolysis in patients with acute cerebral venous sinus thrombosis: a systematic review. Interv Neuroradiol. 2022;159101992211434. https://doi.org/10.1177/15910199221143418.

Lee SK, Mokin M, Hetts SW, Fifi JT, Bousser MG, Fraser JF. Current endovascular strategies for cerebral venous thrombosis: report of the SNIS Standards and Guidelines Committee. J NeuroIntervent Surg. 2018;10(8):803–10. https://doi.org/10.1136/neurintsurg-2018-013973.

Article  Google Scholar 

• Lewis W, Saber H, Sadeghi M, Rajah G, Narayanan S. Transvenous endovascular recanalization for cerebral venous thrombosis: a systematic review and meta-analysis. World Neurosurg. 2019;130:341–50. https://doi.org/10.1016/j.wneu.2019.06.211. The only comparison of efficacy between different types of endovascular treatment.

Article  PubMed  Google Scholar